0001415889-24-007182.txt : 20240307
0001415889-24-007182.hdr.sgml : 20240307
20240307162432
ACCESSION NUMBER: 0001415889-24-007182
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Borgman Anne Elizabeth
CENTRAL INDEX KEY: 0001886388
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38662
FILM NUMBER: 24730487
MAIL ADDRESS:
STREET 1: 9000 VIRGINIA MANOR ROAD
STREET 2: SUITE 200
CITY: BELTSVILLE
STATE: MD
ZIP: 20705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 452441988
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: SUTRO BIOPHARMA INC
DATE OF NAME CHANGE: 20061127
4
1
form4-03072024_090326.xml
X0508
4
2024-03-05
0001382101
SUTRO BIOPHARMA, INC.
STRO
0001886388
Borgman Anne Elizabeth
C/O SUTRO BIOPHARMA, INC.
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CHIEF MEDICAL OFFICER
0
Stock Option (Right to Buy Common Stock)
4.54
2024-03-05
4
A
0
60000
0
A
2034-03-05
Common Stock
60000
60000
D
Restricted Stock Units (RSUs)
2024-03-05
4
A
0
45000
0
A
2028-03-01
Common Stock
45000
45000
D
The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date.
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.
/s/ Edward C. Albini as attorney-in-fact for Anne E. Borgman
2024-03-07